The venture capital arm of Jordan-based Hikma Pharmaceuticals, Hikma Ventures has invested in a $4 million Series A funding round for Canada’s SeamlessMD – the company announced on Thursday, January 27. The investment round was led by MEDTEQ with participation from Anges Québec, AIoT Health, and Sanjay Malaviya, a health IT entrepreneur.
The company said that the fresh funds will be deployed towards its geographical expansion and developing digital services.
Founded in 2012 by Philip Chen (COO), Joshua Liu (CEO), and Willie Kwok (CTO), SeamlessMD is a cloud-based digital patient engagement platform that connects patients with care providers to deliver better patient care in an efficient and timely manner. The platform provides patients with digital care plans, while enabling care providers to receive alerts and monitor them remotely.
Commenting in the investment round, Hamzeh Abdul-Hadi, principal at Hikma Ventures, in a statement quoted,
“We have been incredibly impressed by SeamlessMD’s vision, category-leading clinical evidence, and best-in-class technology platform, and are excited to add them to the diverse portfolio of companies we have invested in that are utilising digital health technology to improve outcomes for patient. SeamlessMD has developed a proven model for health systems to improve patient outcomes at scale, and we are thrilled to support SeamlessMD in advancing their mission and expanding into new markets where Hikma operates to improve the quality of care.”
Joshua Liu, MD, co-founder and CEO of SeamlessMD said,
“Covid19 has accelerated the need for health systems to deliver digital care at scale. Since the pandemic started, we have been rapidly assisting health systems to adapt to the pandemic, including new solutions for COVID-19 digital screening, patient education, and digital pre-surgery monitoring to safely resume surgery,”
Adding to that, Liu said,
“This investment from Hikma Ventures will be critical in enabling us to meet growing customer demand, expand our library of digital care plans and further develop our machine learning platform for risk prediction and optimising patient outcomes. We are ecstatic to be supported by forward thinking, strategic healthcare investors such as Hikma Ventures who share our belief that the future of healthcare is digital,”